Fundamentals in Urology Webcast (2021)

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms.

This course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions, with incorporation of Guideline principles. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners. New for 2021, a half-day program has been added specifically for Advanced Practice Providers (APP’s) that will cover topics and subject matter seen in their specific clinical practices.

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast Only option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials. 

Webcasts will be available on Friday, June 18, 2021.


This year's course features enhanced programming that allows registrants to access additional online learning resources and modules at the convenience of their home for less time away from the office! The online modules include webcasts of content that was removed or reduced from the live program. The online educational modules for 2019 will include the following content:

  • Uro-Ethics
  • Obstructive Uropathy
  • Applications Outcome
  • Renal Physiology
  • Urodynamics
  • Pathology


Membership Category

AUA Member$525.00
AUA Non-Member$655.00

Target Audience

  • Residents
  • Allied Health Professionals
  • Urologists

Learning Objectives

After attending this course, participants will have greater exposure and insight into the following topic areas:

BPH and Stones

  • Discuss medical and surgical management of BPH and utilize an evidence-based approach for selecting the best therapy
  • Describe the basic pathophysiology of nephrolithiasis
  • Identify the indications and options for the medical evaluation of recurrent and first time stone formers
  • Establish an effective algorithm for the medical and surgical management of nephrolithiasis

Infections and Inflammation

  • Discuss the evaluation of a patient with recurrent UTI
  • Distinguish emphysematous pyelonephritis from other renal infections and differences in management
  • Recognize differences in presentation of acute febrile UTI in males and the impact on treatment
  • Identify who should be screened for asymptomatic bacteriuria
  • Apply the AUA Best Practice Statement to the use of prophylactic antibiotics for procedures
  • Identify the true incidence of IC/BPS and CP/CPPS in the US population
  • Explain what is currently believed about the pathophysiology of chronic pelvic pain
  • Describe how to use the AUA guidelines to develop a treatment plan for patients with IC/BPS and CP/CPPS
  • Review current research in pelvic pain and possible new treatment options


  • Review salient concepts of vesicoureteral reflux, urinary tract obstruction and cryptorchidism with urology residents in the early stages of their urology residency training curriculum.
  • Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters
  • Identify clinical situations that may be encountered if aberrant development occurs in any of the above organ systems

Kidney Cancer

  • Recognize the genetic basis and current clinical and surgical management of all types of localized as well as advanced kidney cancer
  • Apply recently released guideline information to diagnose, evaluate, and manage patients with small renal masses (SRMs)

Infertility and Erectile Dysfunction

  • Review female reproductive biology in the infertile couple
  • Describe the rationale and approach to evaluation of the infertile male
  • Explain male reproductive anatomy and physiology
  • Describe a basic clinical overview of male reproductive medicine and surgery

Complications of Urologic Surgery and Adrenal Disorders

  • Recognize complications of urologic procedures, pathophysiologic changes underlying these occurrences, and management strategies to limit patient morbidity
  • Define the fundamentals of adrenal anatomy and physiology integrate into the care of the urologic patient

Imaging for Urologists

  • Describe approach to MR imaging interpretation of various urologic organs with a focus on clinical conditions encountered in practice

Bladder Neurobiology and Pelvic Organ Prolapse

  • Analyze the systematic evaluation and identification of various types of urinary incontinence (UI) and Pelvic Organ Prolapse (POP) in the outpatient setting in order to offer appropriate interventions for treatment
  • Describe the anatomy, innervation and physiology of the lower urinary tract
  • Define findings and treatment considerations  specific to neurological conditions

Bladder Cancer and Bowel Diversions

  • Explain the guidelines based management of invasive and non-invasive bladder cancer
  • Recognize the importance of subtypes of bladder cancer and the role of specific therapies based on these molecular profiles
  • Discuss the rationale behind selection of segment of bowel used in urinary diversion
  • Explain the long term consequences of metabolic changes after urinary diversion and how to mitigate them
  • Describe the surgical principle of compliance and how it relates to surgical technique

Prostate Cancer

  • Review the current status of screening for prostate cancer in the US and understand the role that various markers play in the early detection of the disease
  • Describe the history of M1 Prostate cancer therapies
  • Identify basics in ADT management
  • Discuss basic science and clinical outcomes of new therapies

APP Half-Day Program

  • Outline evidence based surveillance algorithms for urologic cancers and the role of APPs in cancer survivorship programs
  • Review the evaluation of Management of Microscopic Hematuria  based on the AUA 2020 Guidelines
  • Describe principles in management of patients with recurrent UTI (including special populations such as neurogenic bladder patients)
  • Master the physical exam and cognitive components of urological emergencies
Course summary
Course opens: 
Course expires: 

Session 1:  BPH and Stones

Nephrolithiasis I: Physiology, Metabolic Workup and Medical Management of Stone Disease ; Glenn M. Preminger, MD

Nephrolithiasis II:  Surgical Approaches to Stone Disease; Glenn M. Preminger, MD

BPH: Pathophysiology and Management (Medical/Surgical); Nicole L. Miller, MD, FACS

Session 2:  Imaging for Urologists

MRI for Urologists; Nabeel E. Sarwani, MD, FRCR, FSAR

Session 3: Infections and Inflammation

Urologic Infections: Etiology, Patterns and Pathophysiology;   Michel A. Pontari, MD

Interstitial Cystitis and Disorders of Pelvic Pain; Robert J. Evans, MD, FACS

Session 4:  Infertility and Erectile Dysfunction

Infertility and Reproductive Biology in Women and Men; C. Tanrikut, MD, FACS

 Medical and Surgical Management of Erectile Dysfunction; John Mulhall, MD

Session 5: Pediatrics

Embryology, Congenital Anomalies, and Disorders of Sexual Differentiation; Patricio Gargollo, MD

Reflux, Obstruction, and Undescended Testes – Causes and Clinical Implications; Aseem R. Shukla, MD9

Session 6: Complications of Urologic Surgery and KIDNEY CANCER I

Complications of Urologic Surgery; Jay D. Raman, MD, FACS

Genetics and Principles of Molecular Therapeutics of Kidney Cancer; W. Marston Linehan, MD

Session 7: KIDNEY CANCER II and Adrenal physiology

Diagnosis and Management of the Small Renal Mass; Mark Ball, MD

Adrenal Physiology; Benjamin Ristau, MD

Session 8: Bladder Neurobiology and Pelvic Organ Prolapse

Lower Urinary Tract Neurobiology and Functional Bladder Disorders; Gary E. Lemack, MD

Pelvic Organ Prolapse and Stress Urinary Incontinence: Clinical Assessment and Surgical Management; Jennifer T. Anger, MD, MPH

Session 9: Bladder Cancer and Bowel Diversions

Basic Science of Bladder Cancer; Trinity J. Bivalacqua, MD

Bowel Diversions: Physiology Underlying Electrolyte Abnormalities; Tracey Krupski, MD, MPH

Session 10: Prostate Cancer

PSA, Urine Markers and the Science of Cancer Screening; Leonard G. Gomella, MD, FACS

Management of Advanced Prostate Cancer: Drugs, Mechanisms, Disease, Epidemiology and Molecular Mechanisms; Michael B. Williams, MD, MS


Hypogonadism:  Testosterone Replacement and Supplementation; C. Tanrikut, MD, FACS

Microhematuria:  New AUA Guidelines; Jay D. Raman, MD

Nuts and Bolts of Managing PSA Referrals; Stephen H. Culp, MD, PhD

Urology Coding for APP’s; Edna R. Maldonado, CPC, ACS-UR, AHIMA-ICD-10 Trainer

Recurrent UTI Patients:  Evaluation and Management for APP’s; Michel A. Pontari, MD

APP Cystoscopy; Christy Krieg, NP






PDF iconEducation Council Disclosures June 2021.pdf


PDF iconCOI Review Work Group Disclosures 2021.pdf


For a full listing of all faculty disclosures, please visit Fundamentals in Urology Faculty Disclosures and click on the "Faculty" tab. 

AUA Office of Education Staff has nothing to disclose.


Learners will participate in this online educational activity by taking the pre-test, viewing the webcast and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 22.75 hours

Release Date: June, 2021
Expiration Date: June, 2024


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this enduring material for a maximum of 22.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty


The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.


Please login or register to take this course.

AUA Members save 25%!  For more information on membership benefits, visit   


Membership Category

AUA Member$525.00
AUA Non-Member$655.00

Webcast will be available to view on Wednesday, June 18, 2021.

Cancellation Policy

Live Course: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.

Webcast: Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.

Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912. Questions? Call 1-800-908-9414 or email

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before May 1, 2020. If AUA Education & Research cancels this course, registration fees will be refunded in full and notification will be sent by May 8, 2020.

Attendee Information & Policies 

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA). 

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities. 

 Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms. 

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA. 

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.